quinoxalines has been researched along with Granulocytic Leukemia, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar, S; Arpin, CC; Griffin, K; Holmberg-Douglas, N; Lewis, TR; Rodriguez, S; Rueb, KF; Sampson, EM; Smith, J; Stachura, DL; Tomasetti, S | 1 |
| Bazarbachi, A; Bonnet, PA; Deleuze-Masquéfa, C; El Eit, R; Hmadi, R; Iskandarani, A; Mahon, FX; Nasr, R; Saliba, J | 1 |
| Dörken, B; Grille, P; Kaeda, J; le Coutre, P; Manley, PW; Marque, F; Oberender, C; Radimerski, T; Ringel, F; Schwarz, M | 1 |
| Chattopadhyay, A; Chaudhuri, U; Dasgupta, AK; Lahiri, P | 1 |
4 other study(ies) available for quinoxalines and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.
Topics: Animals; Cell Proliferation; Fusion Proteins, bcr-abl; GRB2 Adaptor Protein; Humans; K562 Cells; Kidney; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Binding; Quinoxalines; src Homology Domains; Stromal Cells; Surface Plasmon Resonance; Zebrafish | 2020 |
EAPB0503, a novel imidazoquinoxaline derivative, inhibits growth and induces apoptosis in chronic myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitosis; Piperazines; Pyrimidines; Quinoxalines | 2014 |
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Janus Kinase 2; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Myeloproliferative Disorders; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quinoxalines; STAT5 Transcription Factor; Tumor Suppressor Proteins | 2014 |
Platelet aggregation profile as a marker of hydroxyurea bioavailability through nitric oxide generation in chronic myelogenous leukemia.
Topics: Adult; Biological Availability; Blood Platelets; Cyclic GMP; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitric Oxide; Oxadiazoles; Platelet Aggregation; Quinoxalines; Time Factors | 2006 |